ELI LILLY & CO

CUSIP: 532457908

Market Cap
-
Sector
-
Institutional Owners
0
Institutional Value
-

About

Eli Lilly and Company is a global pharmaceutical leader specializing in the discovery, development, and commercialization of medicines for diabetes, oncology, immunology, and neuroscience. The company is recognized for its extensive portfolio of innovative therapies, including its leadership in the glucagon-like peptide-1 (GLP-1) market. With a long history of medical advancements, Lilly maintains a strong competitive position in the global healthcare industry.

Institutional Holders

Loading...